H1N1 COUNTERMEASURES STRATEGY AND ... - PHE Home

More documents

Recommendations

Info

NBSB Pandemic Influenza Working Group Detailed Report 11:50-12:10 Passive Antibody as a Therapeutic John Beigel (Work done at NIAID, NIH, HHS) 12:10-12:30 Oseltamivir Strategy for Unmet H1N1 Regina Dutkowski Treatment Needs 12:30-1:00 Panel Discussion Ed Cox Debra Birnkrant Fred Hayden Judith Ng-Cashin William Sheridan John Beigel Elizabeth Higgs Questions to consider: What drugs might be available? Options for use during pandemic? Can we accelerate the science and clinical trials? Can we accelerate development of other agents? How do we ensure drugs for severe disease if novel H1N1acquires Oseltamivir (and Peramivir) resistance? 1:00-1:15 Wrap up 1:15 Adjourn 1:30-2:30 Optional Working Lunch Meeting – Consider Next Steps For more information, please visit our Web site: www.hhs.gov/aspr/ompsh/nbsb 4
NBSB Pandemic Influenza Working Group Detailed Report APPENDIX D H1N1 COUNTERMEASURES STRATEGY AND DECISION MAKING FORUM LIST OF PARTICIPANTS PANDEMIC INFLUENZA WORKING GROUP (PIWG) NATIONAL BIODEFENSE SCIENCE BOARD JULY 2009 5
Page 1 and 2:
H1N1 COUNTERMEASURES STRATEGY AND D
Page 3 and 4:
NBSB PIWG H1N1 Countermeasures Stra
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
NBSB Pandemic Influenza Working Gro
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50: NBSB Pandemic Influenza Working Gro
Page 99: NBSB Pandemic Influenza Working Gro
show all

H1N1 COUNTERMEASURES STRATEGY AND ... - PHE Home

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?